Kazia Therapeutics Limited Recorded Big Gain

Kazia Therapeutics Limited (KZIA:NASDAQ) shot up at $1.9, representing a gain of 37.7%. On Thu, Jan 30, 2025, KZIA:NASDAQ hit a New 2-Week High of $1.9. The stock appeared on our News Catalysts scanner on Thu, Jan 30, 2025 at 09:14 AM in the 'MERGER' category. From Thu, Jan 16, 2025, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Thu, Jan 30, 2025 at $2.64 with a volume of 103M+.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Foxx Development Holdings Inc. (FOXX:NASDAQ), 121.11%
- Benson Hill Inc. (BHIL:NASDAQ), 119.44%
- Tectonic Therapeutic Inc Com (TECX:NASDAQ), 113.22%
- Alpha Modus Holdings Inc. (AMOD:NASDAQ), 103.9%
- Dominari Holdings Inc Com (DOMH:NASDAQ), 59.11%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 52.84%
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 52.78%
- F45 Training Holdings Inc. (FXLV:NYSE), 42.86%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 37.68%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 35.58%